ArticleLasers in medical science2026
Effects of low-level laser therapy on the aging process of human dermal fibroblast cells.
Article in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin aging results from intrinsic factors and extrinsic stressors, particularly ultraviolet (UV) radiation, leading to structural and functional deterioration. Low-Level Laser Therapy (LLLT) has emerged as a potential non-invasive intervention. To evaluate the effectiveness of LLLT in mitigating UV-induced aging in human dermal fibroblasts (HDFs). HDFs were exposed to UV-A (365 nm) and red light (650 nm), individually or sequentially. Cell viability and proliferation were assessed via (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay and flow cytometry. Gene expression of collagen synthesis (Col1A1), apoptosis (Bax, Bcl2, Casp8), and DNA methylation (Dnmt3b) were analyzed by qPCR. UV irradiation reduced cell viability temporarily at 24 h, and subsequent treatment with red light after UV-A (UL group) resulted in partial recovery. The percentage of S-phase cells was higher in the UL group at 72 h (P < 0.05), suggesting an increased proliferative activity in this group. Expression of Col1A1 and Dnmt3b increased (P < 0.05, P < 0.01), while apoptotic markers were altered (P < 0.05, P < 0.01), suggesting enhanced collagen production, epigenetic regulation and reduced apoptosis. LLLT is a promising non-invasive approach to counteract UV-induced skin aging and support dermal regeneration. Further studies are required to optimize treatment protocols and validate clinical applications in dermatology and regenerative medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.